1. Home
  2. KRMD vs MIRM Comparison

KRMD vs MIRM Comparison

Compare KRMD & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$5.80

Market Cap

186.3M

Sector

Health Care

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$79.64

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
MIRM
Founded
1980
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.3M
3.4B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
KRMD
MIRM
Price
$5.80
$79.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$5.13
$92.45
AVG Volume (30 Days)
201.0K
790.7K
Earning Date
11-12-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,070,637.00
$471,794,000.00
Revenue This Year
$23.36
$53.78
Revenue Next Year
$18.63
$19.91
P/E Ratio
N/A
N/A
Revenue Growth
22.12
53.66
52 Week Low
$1.86
$36.88
52 Week High
$6.11
$79.95

Technical Indicators

Market Signals
Indicator
KRMD
MIRM
Relative Strength Index (RSI) 64.27 69.86
Support Level $5.44 $63.23
Resistance Level $5.88 $66.77
Average True Range (ATR) 0.35 3.33
MACD -0.05 0.90
Stochastic Oscillator 76.25 98.15

Price Performance

Historical Comparison
KRMD
MIRM

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: